Robert Lenz

A Controlled Trial of Erenumab for Episodic Migraine

Peter J. Goadsby, Uwe Reuter, Yngve Hallström et al. · New England Journal of Medicine · 2017 · 948 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Stewart J. Tepper, Messoud Ashina, Uwe Reuter et al. · The Lancet Neurology · 2017 · 735 citations

Medicine, Neurology, Pharmacology +9

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 696 citations

Pharmacy, Neurology, Pharmacotherapy +12

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

David W. Dodick, Messoud Ashina, Jan Lewis Brandes et al. · Cephalalgia · 2018 · 590 citations

Medicine, Pharmacology, Pharmacotherapy +15

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Hong Sun, David W. Dodick, Stephen D. Silberstein et al. · The Lancet Neurology · 2016 · 360 citations

Pharmacy, Neurology, Preventive Medicine +9